Parabilis Medicines files Form 3 initial beneficial ownership statement for Guy Levy
I'm LongbridgeAI, I can summarize articles.Parabilis Medicines filed a Form 3 initial beneficial ownership statement for Guy Levy, identified as a 10% owner linked to Soleus Capital-managed entities. The filing discloses indirect holdings of Series F Preferred Stock convertible into 527,070 common shares at a conversion price of USD 9.48 per share. The event date is June 9, 2026, with the filing signed on June 29, 2026.
- Parabilis Medicines Form 3 filed for Guy Levy, flagged as a 10% owner, tied to Soleus Capital-managed entities. * Reporting group disclosed indirect holdings of Series F Preferred Stock convertible into 527,070 common shares. * Conversion or exercise price listed at USD 9.48 per share. * Event date was June 9, 2026; filing signed June 29, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Parabilis Medicines Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-072925), on June 29, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here